BSN CAPITAL PARTNERS 13F: Exits Lam Research (LRCX) Stake

BSN Capital Partners closed out its position in Lam Research Corporation LRCX, selling all 133,172 shares during the period. The move appeared in a Form 13F filing with the U.S. Securities and Exchange Commission on October 23, 2026.

LRCX Lam Research Corporation

$230.10 ▲ +24.71% year to date

1M 3M YTD

Daily close · Oct 23, 2026

Inside Bsn Capital Partners's Lam Research Corporation Trade

During the quarter, Bsn Capital Partners completely exited its holdings in Lam Research Corporation LRCX by unloading all 133,172 shares. The fund held 133,172 shares prior to the sale, resulting in a 100.0% reduction that brought the final share count to zero.

Lam Research Corporation Stock Down 11.8%

Lam Research Corporation LRCX closed at $230.10 on the filing date of October 23, 2026, and recently traded around $230.14. The stock sits about 24.4% below its 50-day moving average of $304.53 and about 47.5% below its 52-week high of $438.50, though it remains above its 52-week low of $135.50.

Recent Earnings

Lam Research Corporation LRCX reported trailing-twelve-month revenue of $26.13 billion and earnings of $5.92 per share. The company posted a net profit margin of 32.3% and a return on equity of 70.1%, with year-over-year revenue growth reaching 54.4%. The next earnings release is scheduled for January 27, 2027.

Dividend

Lam Research Corporation LRCX pays an annual dividend of $1.32 per share, giving it a dividend yield of 0.57%. The payout ratio stands at 18.1% of earnings.

Insider Buying and Selling at Lam Research Corporation

Company insiders executed several sales prior to the filing. Ava Harter sold 5,000 shares on August 31, 2026, at an average price of $302.46 for a total value of $1,512,300. Seshasayee Varadarajan sold 59,750 shares on September 2, 2026, at $291.32 per share, totaling $17,406,370. Chief Executive Officer Timothy M Archer sold 30,000 shares on September 9, 2026, at $319.26 per share for $9,577,800. Director Bethany J Mayer sold 9,557 shares on September 9, 2026, at $314.74 per share, realizing $3,007,970.

Analysts Set New Price Targets

Analyst firms updated their views ahead of the filing. On October 22, 2026, UBS maintained a buy rating while lowering its price target to $400.00 from $425.00. Citigroup maintained a buy rating and trimmed its target to $435.00 from $450.00 on October 22, 2026. Morgan Stanley maintained an overweight rating on October 22, 2026, while lowering its target from $385.00 to $339.00. Mizuho maintained an outperform rating on October 22, 2026, adjusting its target down to $360.00 from $365.00. Needham maintained a buy rating on October 22, 2026, reducing its target to $290.00 from $390.00. Overall, the stock carries a consensus strong buy rating from 30 analysts, with a mean price target of $364.03.

About Lam Research Corporation

Lam Research Corporation LRCX designs and builds specialized equipment used to manufacture semiconductor chips. Its systems help fabricators etch and deposit materials to create complex integrated circuits used in electronics worldwide.

Bottom Line

Investors will look toward the next earnings report on January 27, 2027, for further updates on the company's financial health and market demand. Institutional holdings will continue to shift as funds adjust their positions in upcoming quarters.